Factors Affecting the Approach of Pregnant Women to Prenatal Tests
Objectives: Prenatal screening tests reduce the maternal and perinatal mortality as known. In our study, we aimed to investigate which factors affect the pregnant women most on how to take antenatal screening tests. We planned to evaluate the effects of media on pregnant women’s approach to antenatal screening tests.
Materials and methods: 310 pregnant women who were admitted to the pregnancy outpatient clinic within 30 days have been evaluated by a variety of questions.
Results: Follow ups of pregnant women by their gynecologists and family doctors increase the level of knowledge for screening tests. Particularly the pregnant women who do not want to take the diabetes screening test have been mostly affected by the media.
Conclusion: Clinicians who examine to pregnant women firstly have a great duty to inform about them antenatal screening tests. We need to make arrangements on mediatic explanations that affect the pregnant women negatively about screening tests.
Full Text:PDF (Türkçe)
Cunningham FG, Leveno KJ, Bloom SL et al. Prenatal Screening; In William's Obstetrics; 24nd ed. New York City: The McGraw Hill Companies; 2014:283-305.
Committee on Obstetric Practice. "Practice bulletin no. 137: Gestational Diabetes Mellitus." Obstet Gynecol 2013;122:406-16.
Panel, IADPSG Consensus. "International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy." Diabetes care 2010;33(3):676-82.
Karakuş R. Gebelerin İkili ya da Üçlü Testler Hakkındaki Bilgi Düzeyinin Araştırılması. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 2015;12(5):174-8.
Smith DK, Robert WS, Marteau TM. "Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice." BMJ: British Medical Journal 1994; 309(6957):776.
Gürel, AS, Gürel H, Balcan E. Doğum öncesi bakım esnasında gebelik, doğum ve doğum sonrası döneme ilişkin bilgi edinme durumu. Perinatoloji Dergisi 2006;14(2):90-5.
Van Den Berg M, Timmermans DR, Kleinveld, JH, Garcia, E, van Vugt JM, van der Wal G. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women's reasons. Prenatal diagnosis 2005;25(1):84-90.
Dormandy E, Michie S, Hooper R, Marteau TM. Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or a failure to facilitate informed choices?. International journal of epidemiology 2005;34(2):346-52.
Jaques AM, Sheffield LJ, Halliday JL. Informed choice in women attending private clinics to undergo first‐trimester screening for Down syndrome. Prenatal diagnosis 2005;25(8):656-64.
Dormand E, Marteau TM. "Uptake of a prenatal screening test: the role of healthcare professionals' attitudes towards the test. Prenatal diagnosis 2004;24(11):864-8.
Katalinić S, Frković A, Dobi-Babić R. Role of physicians in violence against women in family. Lijecnicki vjesnik 2004;127:146-50.
Statham H, Green J. Serum screening for Down's syndrome: some women's experiences. BMJ 1993;307(6897):174-6.
Ryder IH. Prenatal screening for down syndrome: a dilemma for the unsupported midwife? Midwifery 1999;15(1):16-23.
This work is licensed under a Creative Commons Attribution 4.0 License.